The short-term analysis included 29,442 patients with cannabis dependence matched to 29,442 patients without dependence. Cannabis dependence was significantly associated with an approximately 4-fold higher risk for ED and PDE5i prescription at 3 months to 1 year from diagnosis among all men and those aged 40 years and older and an approximately 3-fold higher risk for men aged 18-39 years, Dr Asanad’s team reported in The Journal of Sexual Medicine. The longer-term analysis included 17,211 men with cannabis dependence matched to 17,211 men without dependence. Cannabis dependence was significantly associated with an approximately 1.2-fold increased risk for ED among all adult men and those aged 40 years and older, the investigators reported. Cannabis Dependence Linked With Erectile Dysfunction, Testosterone Deficiency – https://www.renalandurologynews.com/news/erectile-dysfunction-testosterone-cannabis-dependence
Yikes.
erectile dysfunction
Viagra and Melanoma Risk
Viagra Frisky Might Be Melanoma Risky.
Men who used the erectile-function drug sildenafil (Viagra) had almost twice the risk of melanoma compared with men who never used the drug, a study of 26,000 men showed.
Recent sildenafil use was associated with an 84% greater risk of melanoma.
Daily Aspirin – Yes or No?
Aspirin: FDA Says ‘No’ Others Say ‘Yes’.
I found this article quite helpful in my own decision regarding whether or not to continue my daily aspirin 81 mg dose.
The bump I gave myself on the shin a few weeks ago that bled profusely and took hours to clot was also quite helpful in my decision regarding whether or not to continue my daily aspirin 81 mg dose.
Update 06.06.14
Check out the following link. If you’re an older male you might find this of interest.
http://www.webmd.com/erectile-dysfunction/news/20110303/regular-use-of-painkillers-linked-to-ed
Update 07.26.14
This link takes you to the 2012 Circulation article.
Update 08.04.14
More links for your reading and research pleasure.
Aspirin May Not Protect Against Cardiovascular Disease – Prevention.com.
Benefits of aspirin more modest than previously believed — St George’s, University of London.
Researchers from Professor Kausik Ray’s group at St George’s, University of London investigated the drug’s effectiveness in primary prevention and the prevalence of side effects. They also assessed if aspirin had any impact on the risk of death from cancer among people considered at risk of cardiovascular disease.
They analysed data from nine clinical trials involving over 100,000 participants without a history of cardiovascular disease. Half of the participants took aspirin and half took a placebo. The average participant in the aspirin arm of these trials took aspirin for about six years.
The researchers found that although aspirin in conventional daily or alternate day doses reduced the risk of total cardiovascular disease events by 10 per cent, this was largely due to a reduction in non-fatal heart attacks. It did not include a reduction in other cardiovascular disease events including death from heart attack, or fatal or non-fatal stroke.
The study also showed that this benefit was almost entirely offset by a 30 per cent increase in risk of life-threatening or debilitating internal bleeding events. This means that while one cardiovascular disease event was averted for every 120 people treated with aspirin for about six years, one in 73 people suffered from potentially significant bleeding during the same period.
lifeunderwriter.net 